MYOCARDIAL VIABILITY ASSESSMENT IN ISCHEMIC CARDIOMYOPATHY - BENEFITS OF CORONARY REVASCULARIZATION

被引:149
|
作者
DREYFUS, GD
DUBOC, D
BLASCO, A
VIGONI, F
DUBOIS, C
BRODATY, D
DELENTDECKER, P
BACHET, J
GOUDOT, B
GUILMET, D
机构
[1] Department of Cardio-Vascular Surgery and Transplantation, Hôpital Foch, Paris V University, Suresnes
来源
ANNALS OF THORACIC SURGERY | 1994年 / 57卷 / 06期
关键词
D O I
10.1016/0003-4975(94)90091-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with ischemic heart disease, congestive heart failure, and low ejection fraction are usually referred for orthotopic heart transplantation. Based on results of myocardial viability assessment, we have prospectively used either coronary artery bypass grafting or orthotopic heart transplantation. From January 1990 to June 1992, among 50 patients initially referred for heart transplantation, 46 showing myocardial viability underwent bypass grafting. Forty-five of these 46 patients were men, and the mean age was 58 +/- 12 years (range, 40 to 70 years). Congestive heart failure was present in all patients, and dyspnea was the main symptom in 80% (37/46). Patients were selected according to three criteria. (1) Myocardial viability was primarily assessed by thallium scintigraphy for up to 24 hours (28/46 patients). When results were negative, patients underwent positron emission tomography (20/46 patients). (2) Regional left ventricular function was assessed using gated blood pool single-photon emission computed tomography combined with (3) full hemodynamic evaluation. Results were as follows: end-diastolic volume, 129 +/- 35 mL/m(2); ejection fraction, 0.23 +/- 0.06; cardiac index, 2.4 +/- 0.62 L . min(-1) . m(-2); mean pulmonary artery pressure, 26 +/- 0.90 mm Hg; and mean pulmonary capillary wedge pressure, 16 +/- 1.10 mm Hg. Operative mortality was 2.17% (1/46). During follow-up (mean duration, 18 months), there were three late cardiac-related deaths (arrhythmias) and two noncardiac-related deaths. The 40 long-term survivors are in New York Heart Association class II. Angiography (15 patients) or gated blood pool single photon emission tomography (32) showed improvement in mean ejection fraction to 0.39 +/- 0.13 (range, 0.22 to 0.46). We therefore recommend coronary artery bypass grafting as an alternative to orthotopic heart transplantation whenever myocardial viability is detected by thallium scintigraphy or positron emission tomography, cardiac index is 1.5 L . min(-1) . m(-2) or higher, and mean pulmonary pressure is 40 mm Hg or lower.
引用
收藏
页码:1402 / 1408
页数:7
相关论文
共 50 条
  • [31] Deceleration time in ischemic cardiomyopathy -: Relation to echocardiographic and scintigraphic indices of myocardial viability and functional recovery after revascularization
    Yong, YQ
    Nagueh, SF
    Shimoni, S
    Shan, K
    He, ZX
    Reardon, MJ
    Letsou, GV
    Howell, JF
    Verani, MS
    Quiñones, MA
    Zoghbi, WA
    CIRCULATION, 2001, 103 (09) : 1232 - 1237
  • [32] Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability
    Pagley, PR
    Beller, GA
    Watson, DD
    Gimple, LW
    Ragosta, M
    CIRCULATION, 1997, 96 (03) : 793 - 800
  • [33] Selecting the appropriate patients for coronary artery bypass grafting in ischemic cardiomyopathy—importance of myocardial viability
    Praveen Kerala Varma
    Rohik Micka Radhakrishnan
    Kirun Gopal
    Neethu Krishna
    Rajesh Jose
    Indian Journal of Thoracic and Cardiovascular Surgery, 2024, 40 : 341 - 352
  • [35] STUDIES OF ASSESSMENT OF MYOCARDIAL VIABILITY BY TC-99M SESTAMIBI MYOCARDIAL SCINTIGRAPHY AND APPLICATION IN CORONARY REVASCULARIZATION
    MingZhang YamingLi The Heart Center of Liaoning Provincial HospitalShenyang China
    中国介入心脏病学杂志, 1998, (04) : 181 - 181
  • [36] Relationship Between Myocardial Perfusion-Gated SPECT and the Performance of Coronary Revascularization in Patients With Ischemic Cardiomyopathy
    Romero-Farina, Guillermo
    Candell-Riera, Jaume
    Aguade-Bruix, Santiago
    Ferreira-Gonzalez, Ignacio
    Igual, Albert
    Garcia-Dorado, David
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (10) : 965 - 970
  • [37] Impact of myocardial viability assessment on the beneficial effect of cardiac resynchronization therapy in patients with ischemic cardiomyopathy
    Dalle Mule, J
    Perelli, R
    Mazzella, M
    Martinelli, F
    Proclemer, A
    Scarabeo, V
    Di Sipio, ML
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 176A - 177A
  • [38] Myocardial revascularization in chronic coronary syndromes: does viability matter?
    Scatteia, Alessandra
    Baritussio, Anna
    Bucciarelli-Ducci, Chiara
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (05): : 386 - 392
  • [39] Assessment of Myocardial Viability and Left Ventricular Function in Patients with Ischemic Cardiomyopathy by Gated DISA Imaging
    Deng, Huixing
    Ting, Ji
    Yang, Aimin
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [40] Benefits of coronary revascularisation in diabetic and non-diabetic patients with ischaemic cardiomyopathy: Role of myocardial viability
    Rizzello, Vittoria
    Poldermans, Don
    Biagini, Elena
    Schinkel, Arend F. L.
    Boersma, Eric
    Elhendy, Abdou
    Sozzi, Fabiola B.
    Maat, Alexander
    Roelandt, Jos R. T. C.
    Bax, Jeroen J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (03) : 314 - 320